New Tracers Improve Diagnosis of Cancer and May Be Useful for Treatment
RESTON, VA. - Researchers have identified two new nuclear medicine tracers that make it easier to diagnose and potentially treat cancer. A proof-of-concept investigation, published in the March issue of The Journal of Nuclear Medicine, reports that 68Ga-FAPI positron emission tomography/computed tomography (PET/CT) provides high-contrast images with quality equal to or better than that of the standard 18F-FDG imaging. Further, no diet changes or fasting are needed before beginning imaging with 68Ga-FAPI, and image acquisition times are substantially shorter than with 18F-FDG PET/CT.
“Having an additional diagnostic tool opens up a new door for cancer patients,” said Uwe Haberkorn, MD, professor of nuclear medicine at the University Hospital of Heidelberg and the German Cancer Research Center in Heidelberg, Germany. “For those who are facing unmet diagnostic challenges-unclear tumor segmentation for radiation therapy, suspicion of false-negative findings, or selection of last-line experimental treatment-68Ga-FAPI may help to provide answers.”
To read more please visit:
http://www.snmmi.org/NewsPublications/NewsDetail.aspx?ItemNumber=31189
Source: SNMMI(Society of Nuclear Medicine & Molecular Imaging)